Ignite Creation Date:
2024-05-05 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 9:01 AM
Study NCT ID:
NCT00000236
Status:
COMPLETED
Last Update Posted:
2005-08-17
First Post:
1999-09-20
Brief Title:
Buprenorphine Pharmacology Related to Addiction Treatment - 18
Sponsor:
National Institute on Drug Abuse NIDA
Organization:
National Institute on Drug Abuse NIDA
Study Overview
Official Title:
Buprenorphine Pharmacology Related to Addiction Treatment
Status:
COMPLETED
Status Verified Date:
2002-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine the interactions between buprenorphine and naltrexone and to assess how they may directly impact the clinical issues involving transferring patients from buprenorphine to naltrexone developing a non-abusable form of buprenorphine and enhancing patient acceptability of naltrexone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01-06969-18 | None | None | None |